|
|
|
|
Vol. 10, Issue 4, 1221-1234, April 1999
Type II Receptor in Mouse Mammary Stroma Results in
Increased Epithelial Branching
Department of Cell Biology and The Vanderbilt Cancer Center,
Vanderbilt University, Nashville, Tennessee 37232
Members of the transforming growth factor-
(TGF-
) superfamily
signal through heteromeric type I and type II serine/threonine kinase
receptors. Transgenic mice that overexpress a dominant-negative mutation of the TGF-
type II receptor (DNIIR) under the control of a
metallothionein-derived promoter (MT-DNIIR) were used to determine the
role of endogenous TGF-
s in the developing mammary gland. The
expression of the dominant-negative receptor was induced with zinc and
was primarily localized to the stroma underlying the ductal epithelium
in the mammary glands of virgin transgenic mice from two separate mouse
lines. In MT-DNIIR virgin females treated with zinc, there was an
increase in lateral branching of the ductal epithelium. We tested the
hypothesis that expression of the dominant-negative receptor may alter
expression of genes that are expressed in the stroma and regulated by
TGF-
s, potentially resulting in the increased lateral branching seen
in the MT-DNIIR mammary glands. The expression of hepatocyte growth
factor mRNA was increased in mammary glands from transgenic animals
relative to the wild-type controls, suggesting that this factor may
play a role in TGF-
-mediated regulation of lateral branching. Loss of responsiveness to TGF-
s in the mammary stroma resulted in increased branching in mammary epithelium, suggesting that TGF-
s play an important role in the stromal-epithelial interactions required
for branching morphogenesis.
Corresponding author.
This article has been cited by other articles:
![]() |
K. Roarty and R. Serra Wnt5a is required for proper mammary gland development and TGF-{beta}-mediated inhibition of ductal growth Development, November 1, 2007; 134(21): 3929 - 3939. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Cheng, A. Chytil, Y. Shyr, A. Joly, and H. L. Moses Enhanced Hepatocyte Growth Factor Signaling by Type II Transforming Growth Factor-{beta} Receptor Knockout Fibroblasts Promotes Mammary Tumorigenesis Cancer Res., May 15, 2007; 67(10): 4869 - 4877. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-F. Chen, J.-A. Feng, P. Li, D. Xing, Y. Zhang, R. Serra, N. Ambalavanan, E. Majid-Hassan, and S. Oparil Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling J Appl Physiol, February 1, 2006; 100(2): 564 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Serra and M R Crowley Mouse models of transforming growth factor {beta} impact in breast development and cancer Endocr. Relat. Cancer, December 1, 2005; 12(4): 749 - 760. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Forrester, A. Chytil, B. Bierie, M. Aakre, A. E. Gorska, A.-R. Sharif-Afshar, W. J. Muller, and H. L. Moses Effect of Conditional Knockout of the Type II TGF-{beta} Receptor Gene in Mammary Epithelia on Mammary Gland Development and Polyomavirus Middle T Antigen Induced Tumor Formation and Metastasis Cancer Res., March 15, 2005; 65(6): 2296 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Biswas, A. Chytil, K. Washington, J. Romero-Gallo, A. E. Gorska, P. S. Wirth, S. Gautam, H. L. Moses, and W. M. Grady Transforming Growth Factor {beta} Receptor Type II Inactivation Promotes the Establishment and Progression of Colon Cancer Cancer Res., July 15, 2004; 64(14): 4687 - 4692. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Musters, K. Coughlan, T. McFadden, R. Maple, T. Mulvey, and K. Plaut Exogenous TGF-{beta}1 Promotes Stromal Development in the Heifer Mammary Gland J Dairy Sci, April 1, 2004; 87(4): 896 - 904. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li, W. Qiao, L. Chen, X. Xu, X. Yang, D. Li, C. Li, S. G. Brodie, M. M. Meguid, L. Hennighausen, et al. Squamous cell carcinoma and mammary abscess formation through squamous metaplasia in Smad4/Dpc4 conditional knockout mice Development, December 15, 2003; 130(24): 6143 - 6153. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. S. Wiseman, M. D. Sternlicht, L. R. Lund, C. M. Alexander, J. Mott, M. J. Bissell, P. Soloway, S. Itohara, and Z. Werb Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis J. Cell Biol., September 15, 2003; 162(6): 1123 - 1133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Plaut, A. J. Dean, T. A. Patnode, and T. M. Casey Effect of Transforming Growth Factor-beta (TGF-{beta}) on Mammary Development J Dairy Sci, July 1, 2003; 86(13_suppl): E16 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Denton, B. Zheng, L. A. Evans, X. Shi-wen, V. H. Ong, I. Fisher, K. Lazaridis, D. J. Abraham, C. M. Black, and B. de Crombrugghe Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor {beta} (TGF{beta}) Receptor Leads to Paradoxical Activation of TGF{beta} Signaling Pathways with Fibrosis in Transgenic Mice J. Biol. Chem., June 27, 2003; 278(27): 25109 - 25119. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Ewan, G. Shyamala, S. A. Ravani, Y. Tang, R. Akhurst, L. Wakefield, and M. H. Barcellos-Hoff Latent Transforming Growth Factor-{beta} Activation in Mammary Gland : Regulation by Ovarian Hormones Affects Ductal and Alveolar Proliferation Am. J. Pathol., June 1, 2002; 160(6): 2081 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-a. Yang, B. Tang, G. Robinson, L. Hennighausen, S. G. Brodie, C.-X. Deng, and L. M. Wakefield Smad3 in the Mammary Epithelium Has a Nonredundant Role in the Induction of Apoptosis, but not in the Regulation of Proliferation or Differentiation by Transforming Growth Factor-{beta} Cell Growth Differ., March 1, 2002; 13(3): 123 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Zinser, K. Packman, and J. Welsh Vitamin D3 receptor ablation alters mammary gland morphogenesis Development, January 7, 2002; 129(13): 3067 - 3076. [Abstract] [Full Text] [PDF] |
||||